Alterity Therapeutics (ATHE) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alterity Therapeutics Limited has announced the cessation of 5 million options due to unmet conditions, effective May 7, 2024. This cessation follows the lapse of conditional rights to securities, specifically options expiring on November 29, 2026, with an exercise price of $0.0375. The company’s issued capital will now comprise different classes of quoted and unquoted equity securities, excluding the ceased options.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.